Govt approval to KIHT as CRO expands India’s innovation capabilities
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
AI-enabled wearable remote patient monitoring platform successfully completed pilot deployments in a government super-specialty hospital and emergency ambulances
From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies
Q4 FY26 PAT jumps 44% to Rs. 271 crore, supported by acquisitions, specialty expansion, and diagnostics momentum
Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy
At the institute's 42nd convocation ceremony, Union Minister described its eight-institution MoU initiative as a unique collaborative effort that brings together premier national institutions to create a synergistic research ecosystem
Subscribe To Our Newsletter & Stay Updated